TGFB1 and Crohn disease: Li and colleagues conducted one previous study that presented a mechanism by which leads to increased TGF-β1 activation of SMCs in the intestinal structures, which develops in a certain percentage of patients affected with Crohn’s disease (Li et al., 2013).